University of North Carolina, Chapel HillChapel Hill, North Carolina, United States
Disclosure(s): No financial relationships to disclose
578 - Metformin reduces the risk of Long COVID or Death over 6 months in an Emulated Target Trial of Primarily Omicron-infected Adults without Diabetes or Prediabetes: a New-User, Active-Comparator Analysis Using the National COVID Cohort Collaborative (N3C) Electronic Health Record Database. This research was supported in part by the Intramural/Extramural research program of the National Center for Advancing Translational Science, NIH.
Saturday, October 19, 20242:21 PM – 2:33 PM US PT
